Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$743,390,856
+$56,571,361 QoQ
Shares Held
2,954,184
-6.5% QoQ
Ownership
0.167%
of shares outstanding
% of Portfolio
1.13%
of 13F equity value
Holder Rank
#62
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BESSEMER GROUP INC holds $2,467,290,706 across 16 Drug Manufacturers - General names. ABBV ranks #2 (30.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
923,815 | $1,108,051,512 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
2,954,184 | $743,390,856 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
1,444,022 | $182,437,735 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,080,415 | $138,833,324 | |
| 5 | JNJ |
Johnson & Johnson
|
539,958 | $137,133,128 | |
| 6 | PFE |
Pfizer Inc
|
5,067,281 | $122,020,120 | |
| 7 | AMGN |
Amgen Inc
|
31,001 | $11,226,079 | |
| 8 | NVS |
Novartis AG
|
64,977 | $10,183,191 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $743,390,856 | 2,954,184 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $686,819,495 | 3,157,936 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $711,801,409 | 3,115,241 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $637,653,745 | 2,753,968 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $513,315,026 | 2,765,408 | Shares | Defined | 2025-08-01 | |
| 2025-03-31 | $576,798,707 | 2,752,953 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $197,577,873 | 1,111,862 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $253,913,263 | 1,285,767 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $219,569,264 | 1,280,138 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $241,912,015 | 1,328,457 | Shares | Defined | 2024-08-13 | |
| 2023-12-31 | $213,957,622 | 1,380,639 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $204,043,608 | 1,368,869 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $252,350,498 | 1,873,009 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $298,711,649 | 1,874,328 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $300,419,248 | 1,858,915 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $246,334,264 | 1,835,439 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $312,044,810 | 2,037,378 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $325,190,873 | 2,005,989 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $268,580,115 | 1,983,605 | Shares | Defined | 2022-01-27 | |
| 2021-09-30 | $191,275,295 | 1,773,202 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $198,071,016 | 1,758,443 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $165,631,139 | 1,530,504 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $152,776,288 | 1,425,817 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $124,032,166 | 1,416,054 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $124,144,187 | 1,264,455 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $92,749,968 | 1,217,351 | Shares | Defined | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||